These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


116 related items for PubMed ID: 216484

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Circulating antibodies to the feline leukemia virus and FOCMA in cats.
    Lizonová A, Grófová M.
    Neoplasma; 1983; 30(3):281-6. PubMed ID: 6306490
    [Abstract] [Full Text] [Related]

  • 7. Feline leukemia virus envelope glycoprotein vaccine: preparation and evaluation of immunizing potency in guinea pig and cat.
    Salerno RA, Lehman ED, Larson VM, Hilleman MR.
    J Natl Cancer Inst; 1978 Dec; 61(6):1487-93. PubMed ID: 214605
    [No Abstract] [Full Text] [Related]

  • 8. Retroviral-associated eosinophilic leukemia in the cat.
    Lewis MG, Kociba GJ, Rojko JL, Stiff MI, Haberman AB, Velicer LF, Olsen RG.
    Am J Vet Res; 1985 May; 46(5):1066-70. PubMed ID: 2988377
    [Abstract] [Full Text] [Related]

  • 9. Protection of cats against progressive fibrosarcomas and persistent leukemia virus infection by vaccination with feline leukemia cells.
    Grant CK, de Noronha F, Tusch C, Michalek MT, McLane MF.
    J Natl Cancer Inst; 1980 Dec; 65(6):1285-92. PubMed ID: 6253714
    [Abstract] [Full Text] [Related]

  • 10. Studies of naturally transmitted feline leukemia virus infection.
    Pedersen NC, Theilen G, Keane MA, Fairbanks L, Mason T, Orser B, Che CH, Allison C.
    Am J Vet Res; 1977 Oct; 38(10):1523-31. PubMed ID: 201187
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Neutralization of feline leukemia virus with feline antisera to leukocyte alloantigens.
    Lee TH, Essex M, de Noronha F, Azocar J.
    Cancer Res; 1982 Oct; 42(10):3995-9. PubMed ID: 6286102
    [Abstract] [Full Text] [Related]

  • 18. The immunobiology of the feline leukemia virus.
    Rojko JL, Olsen RG.
    Vet Immunol Immunopathol; 1984 May; 6(1-2):107-65. PubMed ID: 6204435
    [No Abstract] [Full Text] [Related]

  • 19. In vitro activation of feline complement by feline leukemia virus.
    Kobilinsky L, Hardy WD, Ellis R, Witkin SS, Day NK.
    Infect Immun; 1980 Jul; 29(1):165-70. PubMed ID: 6249754
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of humoral immunity tests in FeLV infected cats.
    Charreyre CE, Pedersen N.
    Dev Biol Stand; 1990 Jul; 72():197-200. PubMed ID: 2178116
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.